CompletedNot Applicable

Prospective Multicenter Study to Characterize the REAL-WORLD EVIDENCE Regarding Safety and Performance of the Aspiration Catheters Family

France57 participantsStarted 2022-12-12

Plain-language summary

The purpose of this post market study is to collect clinical data of the Arthesys Aspiration catheters family during percutaneous intervention and/or stenting procedure of vessels in the central and peripheral circulation system, including saphenous vein grafts, to support MDR submission.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient with a percutaneous intervention to a native coronary, saphenous vein graft, or peripheral arteries;
✓. Patient with angiographic evidence of thrombus;
✓. Patient \> or = 50 kg;
✓. Patient \>18 years;
✓. Patient who understands the trial requirements and the treatment procedures and provides written informed consent.

What they're measuring

Efficacy endpoint

Timeframe: up to end of procedure

Safety endpoint

Timeframe: up to end of procedure

Trial details

NCT IDNCT05536167

SponsorArthesys

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts trials